Mike Shelley

Papers

Total Citations

H-Index

About

Mike Shelley is a leading figure in urological oncology, with a focused expertise in the surgical management of upper urinary tract transitional cell carcinoma (UUT‑TCC). His seminal systematic review, "Surgical management for upper urinary tract transitional cell carcinoma (UUT‑TCC): a systematic review" (2012), has garnered 72 citations, establishing a foundational reference for clinicians navigating this aggressive disease. Shelley’s work critically synthesizes evidence on surgical interventions—from radical nephroureterectomy to emerging nephron‑sparing techniques—clarifying that oncological control remains the primary objective. By systematically evaluating outcomes, he has helped define best practices for treating UUT‑TCC, a malignancy historically associated with poor prognosis. His contributions extend beyond this review; Shelley is recognized for advancing the understanding of risk stratification and surgical decision‑making, influencing guidelines that prioritize both cancer eradication and renal function preservation. For students and researchers, his scholarship exemplifies how rigorous systematic reviews can bridge gaps between clinical evidence and practice, offering a clear roadmap for managing a challenging urological cancer. Shelley’s impact is measured not only in citations but in the tangible improvement of surgical protocols and patient outcomes in upper tract urothelial carcinoma.